equityflowunderstand the flow and follow it
EquityFlowCompanies › Vivalyx

Vivalyx

biotech · Aachen, DE

Develops technology to revitalise donor organs via organ preservation fluid.

Funding history

DateRoundAmount
Apr 2024Funding round
Aachen life-science startup Vivalyx raised 5 million euros for its donor-organ preservation technology.
$5.2M
Jun 2023Seed
Aachen life-science startup Vivalyx raised an undisclosed seven-figure sum from transplantation experts, an angel fund and footballer Mario Goetze.

Investors

Tap an investor to see what else they have backed.

Other companies in biotech

Other companies in DE

Other companies at Unknown stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.